Chemomab Therapeutics (CMMB) Shares Outstanding (2017 - 2025)

Chemomab Therapeutics (CMMB) has 9 years of Shares Outstanding (Entity) data on file, last reported at $51.0 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) fell 64.47% year-over-year to $51.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $51.0 million (down 64.47% YoY) and the FY2025 annual result came in at $51.0 million, down 64.47% from the prior year.
• Shares Outstanding (Entity) advanced to $51.0 million in Q4 2025, from $49.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $183.9 million in Q2 2025 to a low of $35.1 million in Q3 2024.
• A 5-year average of $94.8 million and a median of $91.2 million in 2021 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) surged 139708.38% — and 2025, when it slumped 64.47%.
• Tracing CMMB's Shares Outstanding (Entity) over 5 years: stood at $83.0 million in 2021, then grew by 9.7% to $91.0 million in 2022, then climbed by 3.26% to $94.0 million in 2023, then surged by 52.79% to $143.6 million in 2024, then tumbled by 64.47% to $51.0 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $51.0 million (Q4 2025), $49.4 million (Q3 2025), and $183.9 million (Q2 2025), per Business Quant data.